Abstract
Ni(II) complexes were prepared by the reactions of 3,5-di-tert-butylsalicylaldehyde-S-methylisothiosemicarbazone (L) with salicylaldehyde or 2-hydroxy-1-naphthaldehyde in the presence of NiCl2·6H2O. The complexes and starting material L were characterized by physic-chemical analysis and spectroscopic techniques such as 1HNMR, 13CNMR, IR and UV–VIS. Antimicrobial activity studies of L and the two complexes standards strains of bacteria (Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), Bacillus cereus, Enterococcus faecalis, Streptococcus pneumoniae, Listeria monocytogenes, Escherichia coli, Salmonella typhi and Candida albicans) and 22 clinically isolated microorganisms, including multidrug resistant pathogenic microorganisms, were carried out. The free thiosemicarbazone L showed a significant inhibition of the growth all of Gram-positive bacteria tested.
Similar content being viewed by others
References
West DX, Liberta AE, Padhye SB, Chikate RC, Sonawane PB, Kumbharand AS, Yerande RG (1993) Coord Chem Rev 123:49–57
Campbell MJM (1975) Coord Chem Rev 15:279–285
Cowley AR, Dilworth JR, Donnelly PS, Labisbal E, Sousa A (2002) J Am Chem Soc 124:5270–5275
Richardson DR (2002) Biochim Biophys Acta 42:267–281
Asis SE, Bruno AM, Martinez AR, Sevilla MV, Gaozza CH, Romano AM, Coussio JD, Ciccia G II (1999) Farmaco 54:517–525
Debra CQ, Kathy AK, Earl RK (2006) Antivir Res 71(1):24
Rodríguez-argüelles MC, LóPez-Silva EC, Sanmartín J, Pelagatti P, Zani F (2005) J Inorg Biochem 99:2231
Cukurovali A, Yilmaz I, Gur S, Kazaz C (2006) Eur J Med Chem 41(2):201
Teitz Y, Barko N, Abramoff M, Ronen D (1994) Chemotherapy 40:195
WX Hu, Zhou W, Xia C, Wen X (2006) Bioorg Med Chem Lett 16:2213
Campana M, Laborie C, Barbier G, Assan R, Milcent R (1991) Eur J Med Chem 26:273
Nomiya K, Sekino K, Ishikawa M, Honda A, Yokoyama M, Kasuga NC, Yokoyama H, Nakano S, Onodera K (2004) J Inorg Biochem 98:601–615
Salman AKMd (2009) Eur J Med Chem 44:2270–2274
Kızilcıkli İ, Kurt Y, Akkurt B, Genel AY, Birteksöz S, Ötük G, Ülküseven B (2007) Folia Microbiol 52(1):15–25
Belkıs A, Bahri Ü, Tülay B-D, Serap E-K, Zeynep S (2010) Invest New Drugs 28:421–432
Ulkuseven B, Bal T, Sahin M (2006) Rev Inorg Chem 26(4):367
Şahin M, Bal-Demirci T, Pozan-Soylu G, Ülküseven B (2009) Inorg Chim Acta 362:2407–2412
Arion VB, Rapta P, Telser J, Shova SS, Breza M, Lušpai K, Kožišek J (2011) Inorg Chem 50:2918–2931
Lobana TS, Khanna S, Butcher RJ, Hunter AD, Zeller M (2006) Polyhedron 25:2755–2763
Clinical and Laboratory Standards Institute (CLSI) (2006) Methods of dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 7th edn. CLSI, Wayne, p M7-A7
National Committee for Clinical Laboratory Standards (2002) Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, 2nd edn. NCCLS, Wayne, p M27-A2
Yamazaki C (1975) Can J Chem 53:610
Szecsenyi KM, Leovac VM, Iveges EZ, Arman L, Kovacs A, Pokol G, Gal S (1997) Thermochim Acta 291:101
West DX, Salberg MM, Bain GA, Liberta AE (1997) Transit Met Chem 22:180
Yamazaki C (1975) Can J Chem 53:610
Leovac VM, Vjakovic VD, Cesljevic VI (1987) Polyhedron 6:1901
Leovac VM, Cesljevic VI (1988) Polyhedron 7:264
Acknowledgments
This work was supported by the Research Fund of the University of Nevşehir.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Türkkan, B., Sarıboğa, B. & Sarıboğa, N. Synthesis, characterization and antimicrobial activity of 3,5-di-tert-butylsalicylaldehyde-S-methylthiosemicarbazones and their Ni(II) complexes. Transition Met Chem 36, 679–684 (2011). https://doi.org/10.1007/s11243-011-9518-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11243-011-9518-7